Analytical Detection of Fentanyl Exposure

  • Credit:1.0 ACCENT Credit
  • Duration: 1 hour
  • Date:JUN.11.2024 1:00 p.m. - 02:00 p.m.
  • Level: Basic

Price: $0.00

Member Price: $0.00

Rating: Member Average

This live webinar is scheduled in Eastern Time (ET). Convert to your time zone
It will also be available on demand through June 30, 2025, following the live webinar.


The true extent of the synthetic opioid epidemic is likely underappreciated due to the lack of routine diagnostic and forensic monitoring of all possible exposures and contributors. From point-of-care test strips, to immunoassays, to complex mass spectrometric techniques there are several analytical tools available to analytical laboratories for diagnostic assessment and forensic applications, however, they each have their advantages and disadvantages.

This webinar will review the current epidemic, describe analytical tools used for monitoring the epidemic, and highlight the complexity of the ongoing crisis through case studies. The available data on the advantages and disadvantages of different analytical approaches for laboratory detection will be reviewed and an overview of emerging approaches and methodologies will be discussed.

Target Audience

This activity is designed for physicians, lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), medical technologists, toxicologists, and other laboratory professionals overseeing/conducting within this topic.

Learning Objectives

At the end of this session, participants will be able to:

  • Identify the key contributors to the current opioid epidemic
  • Describe the advantages and disadvantages of different analytical approaches for the detection of fentanyl, fentanyl analogs, and other synthetic opioids
  • Discuss the laboratories potential role in uncovering arising trends in the ongoing public health crisis related to opioid exposure


Kara Lynch's photoKara Lynch, PhD, DABCC, FADLM
Professor, Department of Laboratory Medicine
University of California San Francisco
Medical Director, Clinical Chemistry
UCSF Children’s Hospital Oakland
Co-Director, Core Laboratory
San Francisco General Hospital
San Francisco, CA, USA

Disclosures and Statement of Independence

The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.

The following faculty reported financial relationships:

  • Kara Lynch, PhD, DABCC, FADLM
    • Consultant Fee: Siemens Healthcare Diagnostics, Inc.
    • Grant/Research Support: National Institutes of Health, UCSF Resource Allocation Program, Department of Cannabis Control California, San Francisco Department of Public Health, Hound Labs, Inc., Restek Corporation, Integrated Micro-chromatography Systems, Inc., Agilent Technologies Inc., GatorBio, Inc., Siemens Healthcare Diagnostics, Inc.

Content Validity

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.

Accreditation Statement

This activity will be submitted for approval of up to 1.0 ACCENT® continuing education credits.

Successful Completion Statement

Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email

Sponsored by

siemens logo